References to "we", "us", "our" or the "company" are to Juniper II Corp., except
where the context requires otherwise. The following discussion should be read in
conjunction with our financial statements and related notes thereto included
elsewhere in this report ("Report"). You should read the following discussion
and analysis of our financial condition and results of operations in conjunction
with our condensed financial statements and related notes included in Part I,
Item 1 of this Report. This discussion and other parts of this Report contain
forward-looking statements that involve risks and uncertainties, such as
statements of our plans, objectives, expectations and intentions. Our actual
results could differ materially from those discussed in these forward-looking
statements. See "Cautionary Note Regarding Forward-Looking Statements." Factors
that could cause or contribute to such differences include, but are not limited
to, those discussed in Part I, Item 1A "Risk Factors" of our Annual Report on
Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 31, 2022
(the "2021 Annual Report").

Cautionary Note Regarding Forward-Looking Statements

This Report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate" or "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Report. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other filings with the U.S. Securities and Exchange Commission (the "SEC").

Overview

We are a blank check company incorporated in Delaware on December 30, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses ("business combination") that we have not yet identified. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies. Our sponsor ("sponsor") is Juniper II Management, LLC, a Delaware limited liability company and an affiliate of certain of our officers and directors.

Our registration statement for our initial public offering (the "initial public offering") was declared effective on November 3, 2021. On November 8, 2021, we consummated the initial public offering of 29,900,000 units (the "units" and, with respect to the shares of our Class A common stock, $0.0001 par value per share ("Class A common stock"), included in the units sold in the initial public offering (whether purchased in the initial public offering or thereafter in the open market), the "public shares"), including 3,900,000 units to cover over-allotments, at $10.00 per unit, generating gross proceeds of $299.0 million, and incurring offering costs of approximately $17.3 million, of which approximately $10.5 million and approximately $560,000 was for deferred underwriting commissions and offering costs allocated to derivative warrant liabilities, respectively.

Simultaneously with the closing of the initial public offering, we consummated the private placement (the "private placement") of 14,960,000 private placement warrants to our sponsor, each private placement warrant exercisable to purchase one share of Class A common stock at $11.50 per share, at a price of $1.00 per private placement warrant, generating gross proceeds of approximately $15.0 million.

Upon the closing of the initial public offering and the private placement, approximately $305.0 million ($10.20 per unit) of net proceeds, including the net proceeds of the initial public offering and certain of the proceeds of the private placement, was placed in the trust account (the "trust account"), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with


                                       20

--------------------------------------------------------------------------------

Table of Contents



a maturity of 185 days or less or in any open-ended investment company that
holds itself out as a money market fund selected by the company meeting the
conditions of
Rule 2a-7 of
the Investment Company Act, as determined by the company, until the earlier of:
(i) the completion of a business combination and (ii) the distribution of the
trust account, as described below. Except with respect to interest earned on the
funds held in the trust account that may be released to us to pay our taxes, if
any, the funds held in the trust account will not be released until the earliest
to occur of: (a) the completion of our initial business combination; (b) the
redemption of any public shares properly tendered in connection with a
stockholder vote to amend our amended and restated certificate of incorporation
(i) to modify the substance or timing of our obligation to allow redemption in
connection with our initial business combination or to redeem 100% of our public
shares if we do not complete our initial business combination within 18 months
from the closing of the initial public offering (or 24 months, if we extend the
period of time to consummate a business combination) or (ii) with respect to any
other provisions relating to the rights of holders of our Class A common stock;
and (c) the redemption of all of our public shares if we have not completed our
initial business combination within 18 months (or 24 months, if extended) from
the closing of the initial public offering, subject to applicable law. Based on
current interest rates, we expect that interest income earned on the trust
account (if any) will be sufficient to pay our income and franchise taxes.

If we are unable to complete a business combination within 18 months from the
closing of the initial public offering, or May 8, 2023, (or 24 months, if
extended), we will (i) cease all operations except for the purpose of winding
up, (ii) as promptly as reasonably possible but not more than 10 business days
thereafter, redeem the public shares, at
a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust
account including interest earned on the funds held in the trust account and not
previously released to us to pay our tax obligations (less up to $100,000 of
interest to pay dissolution expenses), divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders'
rights as stockholders (including the right to receive further liquidating
distributions, if any), subject to applicable law, and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of the
company's remaining stockholders and the company's board of directors, dissolve
and liquidate, subject in each case to the company's obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable
law.

Results of Operations

Our entire activity since inception up to March 31, 2022 related to our formation, the preparation for the initial public offering, and since the closing of the initial public offering, the search for a prospective initial business combination. We will not be generating any operating revenues until the closing and completion of our initial business combination, at the earliest.


For the three months ended March 31, 2022, we had a net income of approximately
$11.1 million, which consisted approximately $6,000 in interest income from
investments held in the trust account,
non-operating
income of approximately $11.5 million resulting from changes in fair value of
derivative warrant liabilities, offset by approximately $402,000 in general and
administrative expenses, approximately $49,000 in franchise tax expense and
$30,000 in general and administrative expenses - related party.

For the three months ended March 31, 2021, we had a net loss of approximately $51,000, which consisted of approximately $49,000 in franchise tax expense and approximately $2,000 in general and administrative expenses.

Liquidity and Going Concern

As of March 31, 2022, we had approximately $1.3 million in cash and working capital of approximately $1.2 million.

Our liquidity needs prior to the consummation of the initial public offering were satisfied through the payment of $25,000 from our sponsor to cover certain offering costs in exchange for issuance of the founder shares, a loan under a promissory note from our sponsor of $300,000 (the "Promissory Note") and advances from related parties in the amount of approximately $13.1 million. We fully repaid the Promissory Note balance upon closing of the initial public offering. Subsequent from the consummation of the initial public offering, our liquidity has been satisfied through the net proceeds from the consummation of the initial public offering and the private placement held outside of the trust account.

Accordingly, our management has since re-evaluated the liquidity and financial condition and determined that sufficient capital exists to sustain operations for at least one year from the date that the condensed financial statements were issued. Over this time period, the company will be using the funds held outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire and structuring, negotiating and consummating the business combination.

However, in connection with management's assessment of going concern considerations in accordance with FASB ASC Topic 205-40, "Presentation of Financial Statements-Going Concern," our management has determined that these considerations taken together with the mandatory liquidation and subsequent dissolution raise substantial doubt about our ability to continue as a going concern one year from the date that these financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should we be unable to continue as a going concern.


                                       21

--------------------------------------------------------------------------------


  Table of Contents

Related Party Transactions

Founder Shares

On January 21, 2021, our sponsor paid $25,000 on behalf of us to cover certain
offering costs in exchange for issuance of 8,625,000 shares of our Class B
common stock, $0.0001 par value per share ("Class B common stock" and, with
respect to such shares of Class B common stock, the "founder shares"). On
February 4, 2021, we effected a forward stock split that increased the number of
founder shares held by our sponsor from 8,625,000 to 11,500,000. On July 12,
2021, our sponsor surrendered, for no consideration, an aggregate of 5,031,250
founder shares, which we canceled, resulting in an aggregate of 6,468,750
founder shares outstanding. Immediately prior to the consummation of the initial
public offering, we effected a stock dividend with respect to our Class B common
stock, resulting in an aggregate of 7,475,000 shares of Class B common stock
outstanding. The founder shares included an aggregate of up 975,000 shares
subject to forfeiture by our sponsor to the extent that the underwriters' option
to purchase additional units was not exercised in full or in part, so that our
initial stockholders would own, on
an as-converted basis,
20% of our issued and outstanding shares after the initial public offering. The
underwriters exercised their over-allotment option in full on November 8, 2021;
thus, these 975,000 founder shares were no longer subject to forfeiture.

In March and April 2021, our sponsor transferred 35,000 founder shares to each of our independent directors and to Darius Adamczyk, one of our advisors. The transfer of the founder shares is in the scope of Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 718, "Compensation-Stock Compensation" ("ASC 718"). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The founders shares were granted subject to a performance condition (i.e., the occurrence of a business combination). Compensation expense related to the founders shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of March 31, 2022, we determined that a business combination was not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a business combination is considered probable (i.e., upon consummation of a business combination) in an amount equal to the number of founders shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified).

Our sponsor agreed, subject to limited exceptions, not to transfer, assign or sell any of our founder shares until the earlier to occur of: (A) one year after the completion of a business combination or (B) subsequent to a business combination, (x) if the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a business combination, or (y) the date on which we complete a liquidation, merger, capital stock exchange or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Private Placement Warrants

Simultaneously with the closing of the initial public offering, we consummated the private placement of 14,960,000 private placement warrants (the "private placement warrants"), at a price of $1.00 per private placement warrant to our sponsor, generating proceeds of approximately $15.0 million.


                                       22

--------------------------------------------------------------------------------

Table of Contents

Each private placement warrant will be exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the private placement warrants was added to the proceeds from the initial public offering held in the trust account. If we do not complete a business combination within 18 months from the closing of the initial public offering, or May 8, 2023, (or 24 months, if extended), the proceeds of the sale of the private placement warrants will be used to fund the redemption of the public shares (subject to the requirements of applicable law), and the private placement warrants will expire worthless. There will be no redemption rights or liquidating distributions from the trust account with respect to the private placement warrants.

Related Party Loans



Our sponsor agreed to loan us an aggregate of up to $300,000 to cover expenses
related to the initial public offering pursuant to a promissory note dated
January 21, 2021, which was later amended on September 30, 2021. The Promissory
Note
was non-interest bearing
and payable upon the completion of the initial public offering. We fully
borrowed $300,000 under the Promissory Note. In addition, we received additional
advances from related parties of approximately $13.1 million to cover for
certain offering costs
and pre-payment for
private placement warrants. We fully repaid the Promissory Note and the advances
as of the consummation of the initial public offering.

In addition, in order to finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we would repay the working capital loans out of the proceeds of the trust account released to us. Otherwise, the working capital loans would be repaid only out of funds held outside the trust account. In the event that a business combination does not close, we may use a portion of proceeds held outside the trust account to repay the working capital loans but no proceeds held in the trust account would be used to repay the working capital loans. The working capital loans would either be repaid upon consummation of a business combination, without interest, or, at the lender's discretion, up to $1.5 million of such working capital loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant. The warrants would be identical to the private placement warrants. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans.

If we anticipate that we may not be able to consummate the initial business combination within 18 months from the closing of the initial public offering, we may, but are not obligated to, extend the period of time to consummate a business combination by an additional six months (for a total of 24 months to complete an initial business combination). In connection with such extension, our sponsor or affiliates or designees may loan us the required funds to deposit into the trust account an amount of $0.10 per public share, or approximately $3.0 million in the aggregate. Any such payments would be made in the form of a loan (the "extension loans"). The extension loans will be non-interest bearing and payable upon the consummation of the initial business combination. If we complete our initial business combination, we would be obligated to repay such extension loans. Except for the foregoing, the terms of such extension loans, if any, have not been determined and no written agreements exist with respect to such loans.

Commitments and Contingencies

Registration Rights

The holders of the founder shares, private placement warrants and warrants that may be issued upon conversion of working capital loans (and any shares of Class A common stock issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the founder shares) are entitled to registration rights pursuant to a registration rights agreement signed upon the effective date of initial public offering, requiring us to register such securities for resale (in the case of the founder shares, only after conversion to Class A common stock). The holders of the majority of these securities will be entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of a business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements.


                                       23

--------------------------------------------------------------------------------

Table of Contents

Underwriting Agreement

We granted the underwriters of our initial public offering a 45-day option from the date of initial public offering to purchase up to 3,900,000 additional units at the initial public offering price less the underwriting discounts and commissions. The underwriters exercised such over-allotment option in full on November 8, 2021.

The underwriters were entitled to a cash underwriting discount of $0.20 per unit, approximately $6.0 million in the aggregate, paid upon the closing of the initial public offering. In addition, the underwriters are entitled to a deferred fee of $0.35 per unit, or approximately $10.5 million in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates

This management's discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We have identified the following as our critical accounting policies:

Investments Held in the Trust Account

Our portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When our investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When our investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.

Class A Common Stock Subject to Possible Redemption

We account for our Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480, "Distinguishing Liabilities from Equity" ("ASC 480"). Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable shares of Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders' equity. Our shares of Class A common stock feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 29,900,000 shares of Class A common stock subject to possible redemption were presented as temporary equity, outside of the stockholders' equity section of the accompanying balance sheet.



Under ASC 480, we have elected to recognize changes in the redemption value
immediately as they occur and adjust the carrying value of the security to equal
the redemption value at the end of the reporting period. This method would view
the end of the reporting period as if it were also the redemption date of the
security. Effective with the closing of the initial public offering, the company
recognized the accretion from initial book value to redemption amount, which
resulted in charges against
additional paid-in capital
(to the extent available) and accumulated deficit.

                                       24

--------------------------------------------------------------------------------

Table of Contents

Net Income (Loss) Per Share of Common Stock

We have two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. We have not considered the effect of the warrants sold in the initial public offering and private placement to purchase an aggregate of 29,910,000 shares of our Class A common stock in the calculation of diluted loss per share, since such warrants are not yet exercisable. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Derivative Warrant Liabilities


We do not use derivative instruments to hedge exposures to cash flow, market or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC 815, "Derivatives and Hedging" ("ASC 815"). The classification of
derivative instruments, including whether such instruments should be recorded as
liabilities or as equity,
is re-assessed at
the end of each reporting period.

The warrants issued to investors in our initial public offering and the private
placement warrants are recognized as derivative liabilities in accordance with
ASC 815. Accordingly, we recognize the warrant instruments as liabilities at
fair value and adjust the instruments to fair value at each reporting period.
The difference between the fair market value of the private placement warrants
and the initial purchase consideration thereof is recorded as compensation
expense. The liabilities are subject
to re-measurement at
each balance sheet date until exercised, and any change in fair value is
recognized in our statement of operations. The fair value of the public warrants
and private placement warrants were initially and subsequently measured at fair
value using a Black Scholes model. Beginning as of December 22, 2021, the fair
value of the public warrants has been measured based on the listed market price
of such public warrants. The private placement warrants are measured at fair
value using a Black Scholes model at March 31, 2022 and December 31, 2021.

Recent Accounting Pronouncements

See Note 2 to the condensed financial statements included in Part I, Item 1 of this Report for a discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements



As of March 31, 2022, we did not have
any off-balance sheet
arrangements as defined in Item 303(a)(4)(ii) of
Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an "emerging growth company" and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we have elected to rely on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an "emerging growth company," we may not be required to, among other things, (i) provide an auditor's attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding


                                       25

--------------------------------------------------------------------------------

Table of Contents

mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer's compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an "emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses